IRIS

Sfoglia per Titolo

Opzioni
Vai a: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Mostrati risultati da 18.037 a 18.056 di 25.475
Titolo Data di pubblicazione Autore(i) File
Pretargeted radioimmunotherapy effectively inhibits growth of subcutaneous colon carcinoma xenografts in nude mice 1-gen-2009 Schoffelen, R; Sharkey, Rm; Mcbride, Wj; Franssen, G; Eek, A; van der Graaf, Wta; Oyen, W; Goldenberg, Dm; Boerman, Oc
Pretargeted radioimmunotherapy of an anti-CEA bispecific antibody and Lu-177-labeled peptide: a phase I study in patients with advanced colorectal cancer 1-gen-2012 Schoffelen, R; Boerman, Oc; Goldenberg, Dm; Sharkey, Rm; Herpen, Cml; Chang, Ch; Franssen, Gm; Mcbride, Wj; Rossi, Ea; van der Graaf, Wta; Oyen, W
Pretargeted radioimmunotherapy of cancer: Progress step by step 1-gen-2003 Boerman, Oc; van Schaijk, Fg; Oyen, W; Corstens, Fhm
Pretargeted radioimmunotherapy of non-Hodgkin's lymphoma: Best of both worlds? 1-gen-2000 Boerman, Oc; Oyen, W; Corstens, Fhm
Pretargeted Radioimmunotherapy of Prostate Cancer with an Anti-TROP-2xAnti-HSG Bispecific Antibody and a Lu-177-Labeled Peptide 1-gen-2014 van Rij, Cm; Frielink, C; Goldenberg, Dm; Sharkey, Rm; Lutje, S; Mcbride, W; Oyen, W; Boerman, Oc
Pretargeted radioimmunotherapy of prostate cancer with an anti-TROP2 x anti-HSG bispecific antibody 1-gen-2012 van Rij, C; Frielink, C; Sharkey, R; Mcbride, W; Rossi, E; Chang, Ch; Oyen, W; Goldenberg, D; Boerman, O
Pretargeted radioimmunotherapy with Bi-213 in mice with CEA-expressing colon cancer xenografts 1-gen-2015 Heskamp, S; Hernandez, R; Essler, M; Bruchertseifer, F; Morgenstern, A; Oyen, W; Seidl, C; Mcbride, B; Goldenberg, D; Boerman, O
Pretargeting a radiolabeled hapten-peptide with a tri-Fab humanized bispecific antibody (bsMAb) to CEACAM5: First results in patients with colorectal cancer 1-gen-2010 Sharkey, R; Schoffelen, R; Esposito, G; He, Aw; Boerman, O; Oyen, W; Weiner, L; Goldenberg, D
Pretargeting of prostate cancer with an internalizing anti-EGP-1 x anti-HSG bispecific antibody 1-gen-2011 van Rij, C; Frielink, C; Sharkey, R; Goldenberg, D; Mcbride, W; Rossi, E; Chang, Ch; Oyen, W; Boerman, O
Pretargeting of prostate cancer with an internalizing anti-EGP-1 x anti-HSG bispecific antibody 1-gen-2011 van Rij, Cm; Frielink, C; Sharkey, Rm; Goldenberg, Dm; Mcbride, W; Rossi, Ea; Chang, C; Oyen, W; Boerman, Oc
Pretargeting of renal cell carcinoma: Improved tumor targeting with a bivalent chelate 1-gen-1999 Boerman, Oc; Kranenborg, Mhgc; Oosterwijk, E; Griffiths, Gl; Mcbride, Wj; Oyen, W; de Weijert, M; Oosterwijk-Wakka, J; Hansen, Hj; Corstens, Fhm
Pretargeting with bispecific anti-renal cell carcinoma X anti-DTPA(In) antibody in 3 RCC models 1-gen-2005 van Schaijk, Fg; Oosterwijk, E; Molkenboer-Kuenen, Jd; Soede, Ac; Mcbride, Bj; Goldenberg, Dm; Oyen, W; Corstens, Fhm; Boerman, Oc
Pretargeting with labeled bivalent peptides allowing the use of four radionuclides: In-111, I-131, Tc-99, and Re-188 1-gen-2003 van Schaijk, Fg; Oosterwijk, E; Soede, Ac; Oyen, W; Mcbride, Wj; Griffiths, Gl; Goldenberg, Dm; Corstens, Fhm; Boerman, Oc
Pretemporal ("Half-and-Half") Approach for Posterior Circulation Aneurysms in a Patient With Internal Carotid Artery Occlusion 1-gen-2018 Lanzino, Giuseppe; Cannizzaro, Delia; Villa Stefano, L; Meyer Fredric, B
Pretherapy work-up in cancer of the cardia. 1-gen-1997 Bardini, R; Sovernigo, G; Castoro, C
Pretransplant active disease status and HLA class II mismatching are associated with increased incidence and severity of cytokine release syndrome after haploidentical transplantation with posttransplant cyclophosphamide 1-gen-2020 Mariotti, J; Taurino, D; Marino, F; Bramanti, S; Sarina, B; Morabito, L; De Philippis, C; Di Vito, C; Mavilio, D; Carlo-Stella, C; Della Porta, M; Santoro, A; Castagna, L
Pretransplantation pet as major prognostic discriminant in IGEV-treated patients with refractory/relapsed Hodgkin's lymphoma (HL) 1-gen-2007 Balzarotti, M; Magagnoli, M; Luminari, S; Spina, M; Chisesi, T; Pinto, A; Federico, M; Castagna, L; Chiti, A; Michieli, M; Angrilli, F; Marcacci, G; Minuti, F; Tirelli, U; Santoro, A
Pretransplantation therapy with hypomethylating agents in patients with myelodysplastic syndromes receiving reduced-intensity conditioning regimens. 1-gen-2014 Alessandrino, Ep.; DELLA PORTA, MATTEO GIOVANNI
Pretransplatation PET as Major Prognostic Discriminant in IGEV (ifosf-amide, gemcitabine, vinorelbine and prednisone) Treated Patients with Relapsed/Refractory Hodgkin's Lymphoma (HL). 1-gen-2009 Mazza, R; Luminari, S; Magagnoli, M; Spina, M; Chisesi, T; Pinto, A; Federico, M; Anastasia, A; Chiti, A; Michieli, M; Angrilli, F; Castagna, L; Marcacci, G; Giordano, L; Tirelli, U; Santoro, A; Balzarotti, M
Pretreatment DWI with Histogram Analysis of the ADC in Predicting the Outcome of Advanced Oropharyngeal Cancer with Known Human Papillomavirus Status Treated with Chemoradiation 1-gen-2020 Ravanelli, M.; Grammatica, A.; Maddalo, M.; Ramanzin, M.; Agazzi, G. M.; Tononcelli, E.; Battocchio, S.; Bossi, P.; Vezzoli, M.; Maroldi, R.; Farina, D.
Mostrati risultati da 18.037 a 18.056 di 25.475
Legenda icone

  •  file ad accesso aperto
  •  file disponibili sulla rete interna
  •  file disponibili agli utenti autorizzati
  •  file disponibili solo agli amministratori
  •  file sotto embargo
  •  nessun file disponibile